Digoxin After Acute Heart Failure — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Digoxin After Acute Heart Failure — Stella

Home/Acute Heart Failure (AHF)/

View on ClinicalTrials.gov

Recruiting

Back to Acute Heart Failure (AHF) trials

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(1 site)

Argentina

Hospital General de Agudos Dr Cosme Argerich, Buenos Aires, Buenos Aires F.D.

Key details

Phase

Post-approval study

Sponsor

Guillermo Liniado

Collaborators

Hospital General de Agudos "Dr. Cosme Argerich"

Enrollment target

~120 participants

Started

December 2025

Primary completion

December 2027

Age range

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

18 Years – 120 Years

Last updated January 2026